William Radvak
Chief Executive Officer chez MONITOR VENTURES INC.
Fortune : 2 M $ au 31/03/2024
Profil
Mr. William J.
Radvak is an Executive Chairman at NervGen Pharma Corp.
and a President, Chief Executive Officer & Director at Monitor Ventures, Inc. He is on the Board of Directors at Monitor Ventures, Inc. Mr. Radvak was previously employed as an Independent Director by Harrys Manufacturing, Inc., a Chairman & Chief Executive Officer by Silvio Ventures, Inc., a President, Chief Executive Officer & Director by Regency Gold Corp., and a President & Chief Executive Officer by Response Biomedical Corp.
He received his undergraduate degree from the University of British Columbia.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
NERVGEN PHARMA CORP.
2,37% | 28/03/2024 | 1 407 500 ( 2,37% ) | 2 M $ | 31/03/2024 |
Postes actifs de William Radvak
Sociétés | Poste | Début |
---|---|---|
MONITOR VENTURES INC. | Chief Executive Officer | 22/01/2010 |
NERVGEN PHARMA CORP. | Founder | 19/01/2017 |
Anciens postes connus de William Radvak
Sociétés | Poste | Fin |
---|---|---|
CLEAN AIR METALS INC. | Chief Executive Officer | 29/04/2019 |
HARRYS MANUFACTURING INC. | Director/Board Member | 08/02/2019 |
Silvio Ventures, Inc. | Chairman | 18/07/2008 |
RESPONSE BIOMEDICAL CORP | Chief Executive Officer | - |
Formation de William Radvak
University of British Columbia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
MONITOR VENTURES INC. | Non-Energy Minerals |
CLEAN AIR METALS INC. | Non-Energy Minerals |
HARRYS MANUFACTURING INC. | Consumer Non-Durables |
NERVGEN PHARMA CORP. | Health Technology |
Entreprise privées | 2 |
---|---|
Response Biomedical Corp.
Response Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Response Biomedical Corp. engages in the research, development, commercialization, and distribution of diagnostic technologies. The firm serves the medical central-lab testing, point of care testing, and on-site environmental testing markets. It provides RAMP system, which is a portable fluorescence immunoassay-based diagnostic technology that combines the performance of a clinical lab with the convenience of a dipstick test. The company was founded on August 20, 1980 and is headquartered in Vancouver, Canada. | Commercial Services |
Silvio Ventures, Inc. | Finance |